Popular Stories

Investing Ideas

Cyberdyne – Changing Paradigms of Exoskeleton Market

Cyberdyne’s (OTC Pink: CYBQY)  HAL (Hybrid Assistive Limb) lower-body exoskeleton, touted to be the world’s first cyborg – type robot, received a FDA approval to start offering its exoskeleton in the U.S through licensed medical facilities in January 2018. This device can support, enhance and...

New Drugs show promise in curbing the Gonorrhea Menace

Gonorrhoea, caused by a bacterial pathogen N. gonorrhoea, is the second most commonly reported sexually transmitted disease in the U.S alone. The data made available by Centres for Disease Control and Prevention (CDC) shows that in 2017, a total of 555,608 cases of gonorrhoea were reported...

MUSTANG BIO: SOARING TO A NEW HIGH AFTER BUBBLE BOY CURE ANNOUNCEMENT

Mustang Bio’s (NASDAQ: MBIO) shares rose by almost 250% after its development partner, St Jude Children’s Research Hospital in Memphis, published study results that demonstrated that its experimental gene therapy could cure “Bubble Boy” disease or X-SCID, a severe combined immunodeficiency in infants. Figure 1 - Stock...

Is Autologous Stem Cell Therapy the next frontier of medicine?

Stem Cell Therapy is emerging as the future of therapeutics for numerous diseases and disorders which have hitherto been unaddressed. The growing awareness of the regenerative powers of stem cells, along with rising research and development expenditure on stem cell technology will drive the growth...

WordPress Video Lightbox Plugin